CAT# | CPM-1-0425 |
Sequence | SGVENPGGYCL |
Size | 50 Test, 100 Test | Antigen | Virus LCMV | Epitope Origin | LCMV gp276-286 | MHC Restriction | H-2Db | Conjugate | APC |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0275 | HLA-A_02_01 Mtb Ag85A48-56 tetramer-GLPVEYLQV-PE labeled | Inquiry | ||
CPM-1-0610 | HLA-A_02_01 PSCA tetramer-AILALLPAL-BV421 labeled | Inquiry | ||
CPM-1-0148 | HLA-A_02_01 RHAMM tetramer-ILSLELMKL-PE labeled | Inquiry | ||
CPM-1-0297 | HLA-A_02_01 MAGE-A3 112-120 tetramer-KVAELVHFL-APC labeled | Inquiry | ||
CPM-1-0001 | H-2Kb OVA tetramer-SIINFEKL-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
Linaclotide, sold under the brand name Linzess, is a synthetic tetradecapeptide and guanylate cyclase (GC-C) rec ...
Secretin is a 27 amino acid polypeptide that is released during acidification in the duodenal cavity and stim ...
Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...
An overview of Palmitoyl pentapeptide-4 The potential of topical peptides to improve aging skin has been widely discussed in ...